right, strong government research institutes and private sector enterprises which have invested in innovation. The TRIPS …

This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …

spanning 1960 to 2005. It incorporates five types of property rights in pharmaceuticals; six statutory measures of enforcement … then sharply increases due to minimum standards set by the 1995 TRIPS Agreement. …

to patent protection on pharmaceuticals that can affect health care and delivery in developing countries. The potential …) How can developing countries deal with price increases that can result from increased patent protection to ensure access …

The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals …

to patent protection on pharmaceuticals that can affect health care and delivery in developing countries. The potential …) How can developing countries deal with price increases that can result from increased patent protection to ensure access …

products patented outside the country, can no longer produce such drugs due to the introduction of TRIPS-compliant patent …The global pharmaceutical sector is highly patent intensive, and firms rely on product, process and formulation patents … Trade Related Aspects of Intellectual Property Rights (hereafter, the TRIPS Agreement) have been defended on grounds of …

to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility …

right, strong government research institutes and private sector enterprises which have invested in innovation. The TRIPS …

The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti … develops a framework of analysis for the impact of patent rights on biomedical innovation in "technology follower" developing … pharmaceutical industry between November 2004 and January 2005 is used to analyze the impact of patent rights as recognized under the …